1. Home
  2. ANIX vs BHST Comparison

ANIX vs BHST Comparison

Compare ANIX & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.99

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.79

Market Cap

117.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
BHST
Founded
1982
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
117.2M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
ANIX
BHST
Price
$2.99
$4.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$9.00
$14.00
AVG Volume (30 Days)
244.6K
38.1K
Earning Date
03-10-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$32,720,000.00
Revenue This Year
N/A
$116.40
Revenue Next Year
N/A
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
45.88
52 Week Low
$2.33
$4.65
52 Week High
$5.46
$12.80

Technical Indicators

Market Signals
Indicator
ANIX
BHST
Relative Strength Index (RSI) 34.76 40.79
Support Level $2.75 $4.82
Resistance Level $3.09 $4.84
Average True Range (ATR) 0.15 0.40
MACD -0.01 -0.01
Stochastic Oscillator 5.00 7.33

Price Performance

Historical Comparison
ANIX
BHST

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: